⌘K

Login Start Free

Home/Filings/4/0001104659-21-090746

4//SEC Filing

White Mark K. 4

Accession 0001104659-21-090746

CIK 0001477845other

View on SEC.gov Company Profile

Filed

Jul 8, 8:00 PM ET

Accepted

Jul 9, 6:28 PM ET

Size

5.4 KB

Accession

0001104659-21-090746

Insider Transaction Report

Form 4

Period: 2021-07-07

Annovis Bio, Inc.ANVS

Director

Transactions

Award
Stock Option (right to buy)
2021-07-07+4,000→ 4,000 total
Exercise: $102.85Exp: 2031-07-07→ Common Stock (4,000 underlying)

Footnotes (1)

[F1]The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date.

Documents

1 file

4
tm2121908-6_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Annovis Bio, Inc.

CIK 0001477845

Entity typeother

Related Parties

1

filerCIK 0001786183

Filing Metadata

Form type: 4
Filed: Jul 8, 8:00 PM ET
Accepted: Jul 9, 6:28 PM ET
Size: 5.4 KB

View on SEC.gov